Efficacy and safety of transcatheter aortic valve implantation with Edwards SAPIEN 3 and XT in smaller Asian anatomy
| Autor: | Hirofumi Hioki, Naoyoshi Hosogoe, Hideyuki Kawashima, Naoyuki Yokoyama, Yugo Nara, Kumiko Konno, Hiroyuki Kyono, Fukuko Nagura, Shuji Otsuki, Makoto Nakashima, Yusuke Watanabe, Akihisa Kataoka, Ken Kozuma |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty Transcatheter aortic Femoral artery 030204 cardiovascular system & hematology Prosthesis Design Single Center Transcatheter Aortic Valve Replacement 03 medical and health sciences 0302 clinical medicine Asian People Patient age Internal medicine medicine.artery medicine Humans Radiology Nuclear Medicine and imaging Hospital Mortality Prospective Studies 030212 general & internal medicine Aged 80 and over Body surface area medicine.diagnostic_test business.industry Incidence (epidemiology) Interventional radiology Aortic Valve Stenosis General Medicine Anatomy Treatment Outcome Aortic Valve Heart Valve Prosthesis Cardiology Female Cardiology and Cardiovascular Medicine business Edwards sapien |
| Zdroj: | Cardiovascular Intervention and Therapeutics. 33:384-390 |
| ISSN: | 1868-4297 1868-4300 |
| Popis: | We aimed to compare the efficacy and safety of transcatheter aortic valve implantation (TAVI) using Edwards SAPIEN 3 (S3) valve and SAPIEN XT) in smaller anatomy. The new generation S3 TAVI device has been used worldwide; however, its efficacy and safety in smaller Asian anatomy remain unknown. Between February 2014 and March 2017, 166 consecutive patients (S3, 54; XT, 112) were treated with balloon-expandable TAVI in a single center and their outcomes were analyzed. Median patient age was 85 (range: 81–88) years and mean body surface area was 1.41 ± 0.15 m2. A 23-mm size valve was used in S3 and XT groups (70 vs. 62%, p = 0.224). The transfemoral approach was more frequently used in the S3 than in the XT group (96 vs. 72%, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink